Bloomberg reported, citing people familiar with the matter, that DePuy Synthes could be valued at more than $20 billion in a sale.
Johnson & Johnson (JNJ) shares jumped 1% on Thursday following reports that the company is eyeing a potential sale of its orthopedics segment.
Add Asianet Newsable as a Preferred Source
Bloomberg reported, citing people familiar with the matter, that DePuy Synthes could be valued at more than $20 billion in a sale. The drugmaker has been planning to separate the unit.
JNJ is expected to meet possible buyers in the coming weeks with documents and financials it is putting together, the report added.
Get updates to this developing story directly on Stocktwits.<
